Interactions between opioid and chemokine receptors: Heterologous desensitization

Cytokine and Growth Factor Reviews

Volumn 13, Issue 3, 2002, Pages 209-222

  Steele, Amber D ^a   Szabo, Imre ^a   Bednar, Filip ^a   Rogers, Thomas J ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemokine; Desensitization; G protein coupled receptors; Human immunodeficiency virus; Opioid

Indexed keywords

CHEMOKINE RECEPTOR; G PROTEIN COUPLED RECEPTOR; OPIATE RECEPTOR; CELL SURFACE RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN;

DESENSITIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFLAMMATORY DISEASE; LEUKOCYTE; NERVOUS SYSTEM; NONHUMAN; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR UPREGULATION; REVIEW; ANIMAL; BIOLOGICAL MODEL; INFLAMMATION; METABOLISM; SIGNAL TRANSDUCTION;

ANIMAL; GTP-BINDING PROTEINS; HIV; HUMAN; INFLAMMATION; MODELS, BIOLOGICAL; RECEPTORS, CELL SURFACE; RECEPTORS, CHEMOKINE; RECEPTORS, OPIOID; SIGNAL TRANSDUCTION; SUPPORT, U.S. GOV'T, P.H.S.; ANIMALS; HUMANS;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0035992497     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(02)00007-2     Document Type: Review

References (142)

1. Opioids, opioid receptors and the immune response
2. The relevance of opioids and opioid receptors on immunocompetence and immune homeostasis
3. Cloning of a 8-opioid receptor by functional expression
4. The δ-opioid receptor: Isolation of a cDNA by expression cloning and pharmacological characterization
5. Molecular cloning and expression of a rat kappa-opioid receptor
6. Cloning and expression of a cDNA for the rat kappa-opioid receptor
7. cDNA cloning and pharmacological characterization of an opioid receptor with high affinities for kappa-subtype-selective ligands
8. Cloning and functional comparison of κ- and δ-opioid receptor from mouse brain
9. Cloning of a human κ-opioid receptor from the brain
10. Molecular cloning of a rat kappa opioid reveals sequence similarities to the mu and delta opioid receptors
11. Opioid analgesics
12. Specific nonopiate receptors for β-endorphin
13. Murine splenocytes express a naloxone-insensitive binding site for β-endorphin
14. Expression of naloxone-resistant β-endorphin binding sites on A20 cells: Effects of concanavalin A and dexamethasone
15. International Union of Pharmacology Part XXII. Nomenclature for chemokine receptors
16. X-ray structure of sensory rhodopsin II at 2.1-A resolution
17. G protein-coupled receptors and signaling networks: Emerging paradigms
18. Evolving concepts in G protein-coupled receptor endocytosis: The role in receptor desensitization and signaling
19. The many faces of G protein signaling
20. G protein regulatory pathways: Rocketing into the twenty- first century
21. Regulated expression of an endopeptidase that hydrolyses beta-endorphin during differentiation of macrophages and T cells
22. Anti-CD3 activation of human CD4+ T cells increases expression of the intracellular beta-endorphin endopeptidase (IDE/gamma-EpGE)
23. Regulatory mechanisms that modulate signaling by G-protein-coupled receptors
24. Mammalian RGS proteins: Barbarians at the gate
25. Emerging roles for RGS proteins in cell signaling
26. A new family of regulators of G-protein-coupled receptors?
27. GTPase activating specificity of RGS12 and binding specificity of an alternatively spliced PDZ (PSD-95/Dlg/ZO-1) domain
28. Selective regulation of Gαq/11 by an RGS domain in the G protein-coupled receptor kinase, GRK2
29. PDZ domains: Targeting signaling molecules to sub-membranous sites
30. Regulation of G protein-coupled receptor kinases
31. The regulator of G protein signaling family
32. Deficient homologous desensitization of formyl peptide receptors stably expressed in undifferentiated HL-60 cells
33. Mechanisms of agonist-induced down-regulation of the human kappa-opioid receptor: Internalization is required for down-regulation
34. G-protein coupled receptors: Turn-ons and turn-offs
35. Trafficking of the HIV coreceptor CXCR4
36. Phosphorylation of the N-formyl peptide receptor carboxyl-terminus by the G protein-coupled receptor kinase, Grk2
37. G protein-coupled receptor kinases
38. Multiple activation steps of the N-formyl peptide receptor
39. G protein-coupled receptors
40. Removal of phosphorylation sites from the beta 2-adrenergic receptor delays onset of agonist-promoted desensitization
41. Phosphorylation sites on two domains of the beta 2-adrenergic receptor are involved in distinct pathways of receptor desensitization
42. Role of phosphorylation in agonist-promoted beta 2-adrenergic receptor sequestration-defective mutant receptor by beta ARK1
43. Receptor class desensitization of leukocyte chemoattractant receptors
44. Cross-desensitization of receptors for peptide chemoattractants. Characterization of a new form of leukocyte regulation
45. Chemokines and chemokine receptors in the CNS: A possible role in neuroinflammation and patterning
46. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP- I in experimental autoimmune encephalomyelitis
47. Chemokines and chemokine receptors in CNS pathology
48. Chemokines in the cerebrospinal fluid of patients with meningitis
49. Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis
50. Immune cell-derived β-endorphin. Production, release and control of inflammatory pain in rats
51. Gene expression and localization of opioid peptides in immune cells of inflamed tissue: Functional role in antinociception
52. Effects of in vivo and in vitro administration of morphine sulfate upon rhesus macaque polymorphonuclear cell phagocytosis and chemotaxis
53. Activation of mu opioid receptors inhibits microglial cell chemotaxis
54. Opiates transdeactivate chemokine receptors: Delta and mu opiate receptor-mediated heterologous desensitization
55. Bidirectional heterologous desensitization of opioid and chemokine receptors
56. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients
57. Do chemokines mediate leukocyte recruitment in post-traumatic CNS inflammation?
58. Chemoattractant receptor cross-desensitization
59. gp120 envelope glycoproteins of human immunodeficiency viruses competitively antagonize signaling by coreceptors CXCR4 and CCR5
60. CK beta-11/macrophage inflammatory protein-3 beta/EBI1-ligand chemokine is an efficacious chemoattractant for T and B cells
61. Cross-desensitization of receptors for peptide chemoattractants. Characterization of a new form of leukocyte regulation
62. Unidirectional heterologous receptor desensitization between both the fMLP and C5a receptor and the IL-8 receptor
63. Chemoattractant receptor cross-talk as a regulatory mechanism in leukocyte adhesion and migration
64. Down-regulation of the chemokine receptor CCR5 by activation of chemotactic formyl peptide receptor in human monocytes
65. The synthetic peptide WKYMVm attenuates the function of the chemokine receptors CCR5 and CXCR4 through activation of formyl peptide receptor-like
66. Desensitization of chemokine receptor CCR5 in dendritic cells at the early stage of differentiation by activation of formyl peptide receptors
67. Regulation of the human, chemokine receptor CCR 1: Cross-regulation by CXCR1 and CXCR2
68. Differential cross-regulation of the human chemokine receptors CXCR1 and CXCR2: Evidence for time-dependent signal generation
69. Influence of the CCR2-V64I polymorphism on human immunodeficiency virus type I coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5 and CXCR4
70. G protein-coupled signal transduction pathways for interleukin-8
71. Specific interactions of chemoattractant factor receptors with G-proteins
72. 3 phosphorylation in the desensitization of cellular responses to platelet-activating factor
73. 3 phosphorylation by protein kinase A
74. Ligand-induced desensitization of the human CXC chemokine receptor-2 is modulated by multiple serine residues in the carboxylterminal domain of the receptor
75. Polarization of chemoattractant receptor signaling during neutrophil chemotaxis
76. Function of P13Kγ in thymocyte development, T cell activation, and neutrophil migration
77. 3 muscarinic acetylcholine receptor in human SH-SY5Y cells
78. A mitogen-activated protein kinase pathway is required for μ-opioid receptor desensitization
79. Phosphorylation and calmodulin binding of the metabotropic glutamate receptor subtype 5 (mGluR5) are antagonistic in vitro
80. Calmodulin binding to G protein-coupling domain of opioid receptors
81. μ-opioid receptor-mediated ERK activation involves calmodulin-dependent epidermal growth factor receptor transactivation
82. q-mediated mitogen-activated protein kinase activation
83. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes
84. Mu-opioid agonist inhibition of kappa-opioid receptor-stimulated extracellutar signal-regulated kinase phosphorylation is dynamin-dependent in C6 glioma cells
85. Mitogenic signaling via endogenous kappa-opioid receptors in C6 glioma cells: Evidence for the involvement of protein kinase C and the mitogen-activated protein kinase signaling cascade
86. Protein kinase C alpha activates RAF-1 by direct phosphorylation
87. Tyrosine kinases in activation of the MAP kinase cascade by G-protein-coupled receptors
88. 2-adrenergic receptor via phospho-tyr-350, phosphorylates G-protein-linked receptor kinase 2, and mediates agonist induced receptor desensitization
89. Agonist-dependent phosphorylation of the G protein-coupled receptor kinase 2 (GRK2) by Src tyrosine kinase
90. Agonist-induced, G protein-dependent and bindependent down-regulation of the μ-opioid receptor
91. The beta-adrenergic receptor is a substrate for the insulin receptor tyrosine kinase
92. Insulin stimulates sequestration of beta-adrenergic receptors and enhanced association of beta-adrenergic receptors with Grb2 via tyrosine 350
93. Interference with the signaling capacity of CC chemokine receptor 5 can compromise its role as an HIV-1 entry coreceptor in primary T lymphocytes
94. The B-oligomer of pertussis toxin deactivates CC chemokine receptor 5 and blocks entry of M-tropic HIV-1 strains
95. Multiple extracellular elements of CCR5 and HIV-1 entry: Dissociation from response to chemokines
96. Evolution of HIV- I coreceptor usage through interactions with distinct CCR5 and CXCR4 domains
97. HIV-1 entry and macrophage inflammatory protein-1β-mediated signaling are independent functions of the chemokine receptor CCR5
98. Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV- I coreceptor activity
99. HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: Independence from G protein signaling and importance of coreceptor down-modulation
100. Actin-dependent receptor colocalization required for human immunodeficiency virus entry into host cells
101. Human immunodeficiency virus-1 infection requires pertussis toxin-sensitive G-protein-signalling and mediates cAMP down-regulation
102. Macrophalge-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor
103. T cell-tropic Hiv gp120 mediates Cd4 and Cd8 cell chemotaxis through CXCR4 independent of Cd4: Implications for HIV pathogenesis
104. + T cells
105. HIV-1 envelope gp120 inhibits the monocyte response to chemokines through CD4 signal-dependent chemokine receptor down-regulation
106. Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5
107. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4-and SDF-1-deficient mice
108. Signal sequence trap: A cloning strategy for secreted proteins and type I membrane proteins
109. Cytokine and chemokine production in HSV-1 latently infected trigeminal ganglion cell cultures: Effects of hyperthermic stress
110. Human immunodeficiency virus type I infection alters chemokine beta peptide expression in human monocytes: Implications for recruitment of leukocytes into brain and lymph nodes
111. CXC chemokines interleukin-8 (IL-8) and growth-related gene product alpha (GROalpha) modulate Purkinje neuron activity in mouse cerebellum
112. Immune activation: The role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states
113. Nociceptive and inflammatory effects of subcutaneous TNFalpha
114. Counterregulation of interleukin-18 mRNA and protein expression during cutaneous wound repair in mice
115. CD2-mediated CD59 stimulation in keratinocytes results in secretion of IL-1α, IL-6, and GM-CSF: Implications for the interaction of keratinocytes with intraepidermal T lymphocytes
116. Human keratinocytes constitutively express interleukin-18 and secrete biologically active interleukin-18 after treatment with pro-inflammatory mediators and dinitrochlorobenzene
117. Inhibition of keratinocyte apoptosis by IL-15: A new parameter in the pathogenesis of psoriasis?
118. IL-4 enhances keratinocyte expression of CXCR3 agonistic chemokines
119. Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors
120. Chemokines Il-8, GROα, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing
121. Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation
122. Large induction of the chemotactic cytokine RANTES during cutaneous wound repair: A regulatory role for nitric oxide in keratinocyte-derived RANTES expression
123. Chemokines in cutaneous wound healing
124. Spatiotemporal expression, distribution, and processing of POMC and POMC-derived peptides in murine skin
125. Presence of immunoreactive beta-endorphin in human skin
126. Interleukin-1 receptors type I and type II are differentially regulated in human keratinocytes by ultraviolet B radiation
127. Inflammatory and hyperproliferative skin disease in mice that express elevated levels of the IL-1 receptor (type I) on epidermal keratinocytes. Evidence that IL-1-inducible secondary cytokines produced by keratinocytes in vivo can cause skin disease
128. Delayed wound healing in CXCR2 knockout mice
129. Characterization of the CC chemokine receptor 3 on human keratinocytes
130. Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro
131. Expression of mu-opiate receptor in human epidermis and keratinocytes
132. β-endorphin stimulates cytokeratin 16 expression and down-regulates μ-opiate receptor expression in human epidermis
133. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress
134. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity
135. Differences in cytokine and chemokine responses during neurological disease induced by polytropic murine retroviruses map to separate regions of the viral envelope gene
136. Diffferential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s
137. CCR5 is characteristic of Th 1 lymphocytes
138. Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells
139. Defects in the generation of IFN-γ are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein-1α, or CCR2-deficient mice
140. Role of C-C chemokine receptor 5 in organ-specific and innate immunity to Cryptococcus neoformans
141. Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor
142. Chemokines in the CNS: Plurifunctional mediators in diverse states